39739-49-6

Upstream product

• 67-56-1 methanol 
• 874-90-8 4-methoxybenzonitrile 

Downstream Products

• 5925-50-8 O-methyl 4-methoxybezenecarbothioate 
• 1638156-66-7 4-ethynyl-2,5-bis(4-methoxyphenyl)pyrimidine 
• 1638156-61-2 4-ethynyl-2-(4-methoxyphenyl)-5-(4-methylphenyl)pyrimidine 
• 1638156-56-5 4-ethynyl-2-(4-methoxyphenyl)-5-phenylpyrimidine 
• 1638156-51-0 5-(4-chlorophenyl)-4-ethynyl-2-(4-methoxyphenyl)pyrimidine 
• 1638156-46-3 4-ethynyl-2-(4-methoxyphenyl)-5-(4-nitrophenyl)pyrimidine 
• 1379505-90-4 C₁₆H₁₇NO₄S 
• 1379505-98-2 C₂₆H₃₁NO₃SSi 
• 51721-68-7 4-methoxybenzamidine hydrochloride 

Relevant academic research and scientific papers

Transition-metal-free approach to 4-ethynylpyrimidines via alkenynones

A practical approach to the synthesis of 4-ethynylpyrimidines by the condensation of arylamidines with 2-aryl-1-ethoxy-5-(trimethylsilyl)pent-1-en-4- yn-3-ones has been developed. As these latter ketones are easily accessible from bis(trimethylsilyl)acetylene and arylacetyl chlorides, the regioselective condensation reported herein provides a facile access to both TMS-protected and unprotected 4-ethynylpyrimidines in yields of up to 85%. Copyright

Efficient synthesis of α-tertiary α-silylamines from aryl sulfonylimidates via one-pot, sequential C-Si/C-C bond formations

An efficient and flexible route for the synthesis of α-tertiary (α,α-dibranched) α-silylamines via sequential reactions of sulfonylimidates using readily available phenyldimethylsilyllithium and Grignard reagents is described. The procedure allows successive formation of C-Si/C-C bonds in a single flask.

6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS

The present invention is directed to 6-(1H-imidazo-1-yl)-2-aryl and 2-heteroaryl quinazoline and quinolines derivatives, compounds of formula (I), their pharmaceutical acceptable salts and solvates and corresponding pharmaceutical compositions, that acts

Pyrimidine derivatives and drugs

The object of the present invention is to obtain new class of compounds which have improving effect on learning and memory disorders with good selectivity in central nervous system and little side effects and then to provide a good medicine for treatment